White House pulls nomination of Heidi Overton to lead FDA
AI Summary
The White House has withdrawn the nomination of Heidi Overton to head the FDA due to strong opposition from Senate Republicans, who hold a slim majority in the Senate. This move comes just before a crucial vote in the Senate health committee, where Republicans' one-vote advantage could have been jeopardized. This decision underscores the intense political tensions surrounding healthcare leadership appointments and highlights the broader implications for FDA oversight and regulatory policy in the U.S.
Original Source
Read the full article at Thehill →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.